Glibornuride is a synthetic sulfonylurea compound, appearing as a white to off-white solid, used primarily as an active pharmaceutical ingredient (API) in the treatment of type 2 diabetes mellitus. It functions as an oral hypoglycemic agent by stimulating insulin release from the pancreas, thereby lowering blood sugar levels. This reagent is effective for managing blood glucose in patients unresponsive to diet and exercise alone and is often part of broader diabetes management strategies including lifestyle changes and other therapies. With a purity of 98%, it conforms to structural standards via IR and NMR spectroscopy. Regular monitoring is advised to prevent hypoglycemia, a potential side effect.